Skip to main content

Table 2 Correlation of tumor CCT6A expression with clinical features

From: Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma

Items Tumor CCT6A expression P value
Low (n = 200) High (n = 181)
Age, No. (%)    0.239
 ≤60.0 years 106 (53.0) 85 (47.0)  
 >60.0 years 94 (47.0) 96 (53.0)  
Gender, No. (%)    0.458
 Female 53 (26.5) 42 (23.2)  
 Male 147 (73.5) 139 (76.8)  
History of smoke, No. (%)    0.107
 No 83 (41.5) 90 (49.7)  
 Yes 117 (58.5) 91 (50.3)  
History of drink, No. (%)    0.565
 No 124 (62.0) 107 (59.1)  
 Yes 76 (38.0) 74 (40.9)  
Hypertension, No. (%)    0.774
 No 122 (61.0) 113 (62.4)  
 Yes 78 (39.0) 68 (37.6)  
Hyperlipidemia, No. (%)    0.824
 No 136 (68.0) 125 (69.1)  
 Yes 64 (32.0) 56 (30.9)  
Diabetes, No. (%)    0.479
 No 170 (85.0) 149 (82.3)  
 Yes 30 (15.0) 32 (17.7)  
Differentiation, No. (%)    0.627
 Well 35 (17.5) 21 (11.6)  
 Moderate 112 (56.0) 116 (64.1)  
 Poor 53 (26.5) 44 (24.3)  
Tumor size, No. (%)    0.106
 ≤5.0 cm 130 (65.0) 103 (56.9)  
 >5.0 cm 70 (35.0) 78 (43.1)  
LYN metastasis, No. (%)    0.001
 No 145 (72.5) 102 (56.4)  
 Yes 55 (27.5) 79 (43.6)  
TNM stage, No. (%)    0.002
 I 82 (41.0) 49 (27.1)  
 II 55 (27.5) 52 (28.7)  
 III 63 (31.5) 80 (44.2)  
CEA, No. (%)    0.022
 Normal (≤5.0 ng/mL) 95 (47.5) 65 (35.9)  
 Abnormal (>5.0 ng/mL) 105 (52.5) 116 (64.1)  
  1. Comparison was determined by chi-square test or Wilcoxon rank-sum test. CCT6A chaperonin containing TCP1 subunit 6A; LYN lymph node; CEA carcinoembryonic antigen